ClinicalTrials.gg

Program

TolaSure Topical Gel

Also written as “5% TolaSure Topical Gel”.

Its studies are mostly in Epidermolysis Bullosa Simplex, led by BioMendics.

Furthest: phase 2, since Sep 11, 20194 company-led studies, 1 open or runningNext primary completion: Jan 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
BioMendics41 open or runningphase 2since Sep 11, 2019Jul 10, 2018Jan 2027phase 2 · NCT07027345

Also a collaborator on its studies: Symbio.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jul 10, 2018First study: phase 1 study in Wound HealingFirst studyNCT03620175 · 22 enrolled · United States
  2. Sep 11, 2019Phase 2 study in Wound HealingNCT04088357 · 72 enrolled · United States
  3. Sep 21, 2021Phase 1 study in Epidermolysis Bullosa SimplexNCT05062070 · 6 enrolled · United States
  4. Jun 9, 2025Phase 2 study in Epidermolysis Bullosa SimplexNCT07027345 · 40 planned · United States

Ahead

  1. Jan 2027Primary completion: phase 2 study in Epidermolysis Bullosa SimplexNCT07027345

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07027345Epidermolysis Bullosa Simplex · United States2RecruitingJan 202740
NCT05062070Epidermolysis Bullosa Simplex · United States1CompletedJun 22, 20236
NCT04088357Wound Healing · United States2CompletedApr 22, 202072
NCT03620175Wound Healing · United States1CompletedDec 12, 201822

How it is read

Names in the registry

  • “TolaSure Topical Gel”, 3 entries
  • “5% TolaSure Topical Gel”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.
TolaSure Topical Gel (BioMendics): development program | ClinicalTrials.gg